Key result
UK Biobank establishes multiomics cohort of ~500,000 adults to advance chronic disease research.
Cohort (n=500,000)
Yes
The UK Biobank is a massive, accessible cohort study providing multiomics and clinical data to facilitate research on chronic conditions including cardiovascular disease.
An increasing number of people are now living with cardiovascular disease (CVD), with concomitant CVD-related hospitalizations, operations, and prescriptions. To ultimately deliver optimal cardiovascular care, access to population-based biobanks with data on multiomics, phenotypes, and lifestyle risk factors are crucial. UK Biobank is a cohort study that incorporated data between 2006 and 2010 from over half a million individuals (40 to 69 years of age) at recruitment from across the United Kingdom. As one of the most accessible, largest, and in-depth cohort studies in the world, UK Biobank continues to enhance the resource with the addition of data from various omics platforms (eg, genomics, metabolomics, proteomics), multimodal imaging, self-reported risk factors and health outcomes, and linkage to electronic health records. The vision of UK Biobank is to allow as many researchers as possible to apply their expertise and imagination to undertake research to prevent, diagnose, and treat a wide range of chronic conditions, including CVD.
No takes yet. Share an insight, caveat, or question.
Caleyachetty et al. (2021) reported a cohort. The UK Biobank is a population-based cohort study that recruited over 500,000 individuals aged 40 to 69 years to provide multiomics and clinical data for chronic disease research.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: